Research data from A. Fritsche and colleagues update understanding of insulin-dependent diabetes therapy

Scientists discuss in 'Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study' new findings in insulin-dependent diabetes. In this recent report published in the journal Diabetes, Obesity and Metabolism, researchers in Tubingen, Germany conducted a study "To compare the efficacy and safety of an intensified insulin regimen, using insulin glargine (glargine) once daily and pre-meal insulin glulisine (glulisine) (basal-bolus), with a conventional therapy, using premixed insulin (premix) twice daily. This 52-week, open-label, randomized, multinational, multicentre trial included 310 subjects with type 2 diabetes...

Want to see the full article?

• Purchase this article for only $3.00